论文信息 - P-25 Tislelizumab monotherapy for patients with previously treated advanced hepatocellular carcinoma (HCC): RATIONALE-208 Chinese subpopulation - 字舞流文

P-25 Tislelizumab monotherapy for patients with previously treated advanced hepatocellular carcinoma (HCC): RATIONALE-208 Chinese subpopulation

G. Shao | T. Zhang | Y. Chen | Y. Bai | Z. Li | Z. Meng | W. Fang | C. Xie | B. Li | J. Wu | Z. Ren | M. Hou | A. Cheng | C. Hsu | J. Hou | H. Pan | S. Chica-Duque | C. Yen | S. Hu | Y. Liu